UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...

UiPath delivered a beat-and-raise quarter and was promoted into a midcap index. Shares of automation software company UiPath ...

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath ( PATH +2.94%) defied critics in ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate as it looks to become an AI agent orchestration platform. UIPath's ...

CEO and Chairman, Dines Daniel, sold shares worth around $1.5 million earlier in the week. ・He sold 90,000 shares of the ...

UiPath Test Cloud recognized among top autonomous testing solutions with highest possible scores in vision, roadmap, and five other criteria UiPath (NYSE: PATH), a global leader in agentic automation, ...

UiPath Inc. (NYSE: PATH) was recently added to the S&P MidCap 400 index, replacing Synovus Financial Corp., reflecting the automation company's increased scale and market presence. This index ...

UiPath, Inc. (NYSE: PATH) shares are trading higher Wednesday after it was announced that the company replace Synovus Financial in the S&P MidCap 400. What To Know: S&P Dow Jones Indices said UiPath ...

UiPath, which specializes in robotic process automation software, has been expanding its presence in the enterprise automation market. The addition to the midcap index represents a milestone for the ...